REVERSASP
reverSASP Therapeutics creates innovative new drugs for aging-related diseases targeting senescent cells. With its deep understanding of underlining biology of aging-related diseases, it focuses on Senescence-associated secretory phenotype, or SASP, as a drug target.
REVERSASP
Industry:
Biotechnology
Founded:
2022-01-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.reversasp.com
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Euro GStatic Google Static Content Google Identity Platform Google Sites
Investors List
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Seed Round - reverSASP
